Association Between Common Infections and Incident Post-Stroke Dementia: A Cohort Study Using the Clinical Practice Research Datalink
Received 4 May 2020
Accepted for publication 23 June 2020
Published 21 August 2020 Volume 2020:12 Pages 907—916
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Professor Henrik Toft Sørensen
Caroline E Morton,1,2 Harriet J Forbes,1 Neil Pearce,3 Liam Smeeth,1 Charlotte Warren-Gash1
1Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK; 2EBM DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK; 3Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK
Correspondence: Caroline E Morton Morton
EBM DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter, Woodstock Road, Oxford OX2 6GG, UK
Tel +44 1865 289300
Email [email protected]
Purpose: To investigate the association between common infections and post-stroke dementia in a UK population-based cohort.
Materials and Methods: A total of 60,392 stroke survivors (51.2% male, median age 74.3 years, IQR 63.9– 82.4 years) were identified using primary care records from the Clinical Practice Research Datalink (CPRD) linked to Hospital Episode Statistics (HES) with no history of dementia. Primary exposure was any GP-recorded infection (lower respiratory tract infection (LRTI), urinary tract infection (UTI) requiring antibiotics, skin and soft tissue infection requiring antibiotics) occurring after stroke. The primary outcome was incident all-cause dementia recorded in primary care records. In sensitivity analyses, we restricted to individuals with linked hospital records and expanded definitions to include ICD-10 coded hospital admissions. We used multivariable Cox regression to investigate the association between common infections and dementia occurring from 3 months to 5 years after stroke.
Results: Of 60,392 stroke survivors, 20,969 (34.7%) experienced at least one infection and overall 4512 (7.5%) developed dementia during follow-up. Early dementia (3 months to 1-year post-stroke) risk was increased in those with at least one GP-recorded infection (HR 1.44, 95% CI 1.21– 1.71), with stronger associations when hospitalised infections were included (HR 1.84, 95% CI 1.58– 2.14). Late dementia (1– 5 years) was only associated with hospitalised, but not with GP-recorded, infections.
Conclusion: There was evidence of an association between common infections and post-stroke dementia, strongest in the 3– 12 months following stroke. Better understanding of this relationship could help inform knowledge of pathways to dementia post-stroke and targeting of preventive interventions.
Keywords: post-stroke dementia, infections, cohort study, electronic health records
There are over 1.2 million stroke survivors in the UK,1 where stroke is the commonest cause of complex disability. Cognitive problems contribute substantially to post-stroke disability, and while physical impairments will often improve after stroke, cognitive function may worsen with time. The incidence of post-stroke dementia typically ranges from 7–20% in community-based studies, but may reach 40% in hospital-based studies.2 Comparisons between studies are limited by differing definitions and study populations.
Risk factors for post-stroke dementia include demographic factors (older age, female sex, non-White ethnicity), existing cognitive decline, location and type of stroke, as well as the presence of small vessel disease or cortical atrophy on neuroimaging.2–4 Delirium and early seizures5 after stroke are associated with dementia risk,5,6 although these factors suggest increased stroke severity, itself a risk factor for post-stroke dementia. The role of common infections in dementia risk is debated. Infections could act through systemic inflammatory pathways to trigger a disordered microglial response in the aged brain.7 While infections in stroke survivors may indicate a more severe stroke, they also occur after mild strokes. It is unclear whether type, frequency or severity of infections affects dementia risk.
Better understanding of the relationship between infections and dementia in the post-stroke setting will help to inform development and targeting of interventions to preserve cognitive function after stroke. We therefore aimed to investigate the association between common infections and post-stroke dementia in a UK population cohort using linked health data.
Materials and Methods
Data Sources and Study Design
We conducted a cohort study using the Clinical Practice Research Datalink (CPRD). CPRD Gold contains anonymised GP records of Read-coded diagnoses, investigations, prescriptions and referrals, patient demographics and registration information. Covering around 8% of the UK population, it is broadly representative by age, gender, ethnicity and mortality.8 Around 75% of English CPRD practices are linked to Hospital Episode Statistics (HES). The HES Admitted Patient Care database contains ICD-10 coded records of admissions to all NHS hospitals in England from 1997.9
We included adults aged ≥40 years who survived an incident first stroke occurring from 01/01/2005-31/12/2016, with at least 1 year of follow-up prior to stroke. Stroke was defined as the first record of any stroke type (ischaemic, haemorrhagic or unspecified) in CPRD or HES according to codelists developed and refined with clinicians. Stroke-specific diagnostic codes in EHRs have a high validity (positive predictive value≥90%).10 We excluded individuals with dementia before stroke and those who died or had a new dementia record in the 3 months after stroke.
Definition of Exposure and Outcome
The primary exposure was GP-recorded infection occurring after stroke, defined as lower respiratory tract infection (LRTI), urinary tract infection (UTI) treated with antibiotics or skin/soft tissue infection (SSTI) treated with antibiotics. An algorithm for identifying infections that built upon existing codelists11–13 was developed and reviewed by two practising clinicians (appendix 1). Prescription data was used to identify antibiotics given on the day of infection. Exposure status was time-varying, so patients contributed person time to the unexposed category until exposure to an infection, at which point they contributed person time to the exposed category. In sensitivity analyses of patients with linked hospital data, the exposure definition was expanded to include ICD-10 coded infections occurring in hospital (an infection code in any position in the record) as well as community-acquired infections resulting in hospitalisation (an infection recorded as the primary diagnosis). In secondary analyses, we explored the effects of number and type of infections, with multiple codes occurring within 28 days considered to relate to the same infectious episode.
The primary outcome was all-cause dementia, identified through clinical Read codes in CPRD (or ICD-10 codes in HES for analyses restricted to those with linked data) dated from the first record (appendix 2). Dementia was divided into early post-stroke dementia (3 months to 1 year) and late post-stroke dementia (1 to 5 years). We focused on dementia occurring from 3 months after stroke to avoid misclassifying delirium or other reversible cognitive changes associated with stroke as dementia.2 Patients whose first dementia code suggested prevalent (rather than incident) dementia were excluded.
Definition of Covariates
We extracted data on age and sex, and identified categories of ethnicity from CPRD and HES data using an approach previously described.14,15 Socio-economic status was assessed at practice level using quintiles of the Index of Multiple Deprivation 2016.16 History of depression, diabetes, myocardial infarction and atrial fibrillation before stroke was defined using CPRD clinical diagnostic codes. Use of statins, blood-pressure lowering medication, and immunosuppressant medication in the two years prior to the stroke was identified from CPRD prescription records. Baseline alcohol use, smoking status and the nearest BMI measurement prior to stroke were also taken from CPRD. Prescription of an anti-platelet agent within 90 days of stroke was identified from CPRD prescription records. We identified new depression diagnoses by depression Read codes following stroke, in patients not coded with depression in the two years prior to stroke. Second or subsequent strokes were identified using ICD-10 codes in the primary diagnosis field in HES, with repeated stroke codes within 28 days considered part of the same episode. We did not consider repeated CPRD stroke codes as second episodes, as multiple GP consultations in the post-stroke period may include stroke codes but are unlikely to represent acute events.
Follow-up began at 3 months after stroke and ended at the earliest of incident dementia, death, transfer out, practice final data collection date, 5 years post-stroke or 31/12/2016. We described the study population at time of stroke and compared characteristics by exposure and outcome variables. We calculated rates of early and late dementia per 1,000 person years at risk (PYAR) with 95% confidence intervals for each exposure category. We developed multivariable Cox regression models to assess the relationship between the time-updated primary exposure any GP-recorded infection and early and late dementia using CPRD data only, first adjusting for age and sex, and then including additional covariates. We carried out several sensitivity analyses restricted to patients with linked CPRD-HES data, which included: 1) repeating the primary analysis in patients with linked data to increase ascertainment of dementia; 2) expanding the definition of infection to include infections recorded in either GP or hospital records (any position), or in GP or hospital records (first position only); and 3) repeating all analyses excluding infections occurring within 3 months of stroke. We then explored the effect of number of infection episodes and first infection type. Likelihood ratio tests were used to calculate p-values. Analyses were carried out using Stata version 15. Analytic code is available at GitHub (https://github.com/CarolineMorton/stroke-infection-research-code).
This study was approved by CPRD’s Independent Scientific Advisory Committee (17_176R) and the London School of Hygiene & Tropical Medicine Research Ethics Committee (14,319).
Description of Study Cohort
We included 60,392 stroke survivors with a median 2.60 years (IQR 0.97–4.75) of follow-up (Figure 1). Just over half were men (51.2%) with a median age of 74.3 years (IQR 63.9–82.4 years). Median consultation frequency was 12.3 per year pre-stroke, rising to 24.2 per year after stroke. A total of 44,057 GP-recorded infections after stroke were identified for 20,969 patients (34.7%), median 2 infections per person (IQR 1–3). First infections comprised 53.6% LRTIs, 33.2% UTIs and 13.1% SSTIs. Linked HES data were available for 64.9%. Table 1 shows study participants’ characteristics overall and by infection status.
Table 1 Characteristics of Study Participarticipants
Figure 1 Flowchart of study participants.
Overall, 4512 (7.5%) patients developed dementia 3 months to 5 years post-stroke, of whom 1406 (31.2%) developed early dementia (rate 35.13 per 1000 PYAR [95% CI 33.34–37.02]) and 3106 (68.8%) developed late dementia (rate 25.80 per 1000 PYAR [95% CI 24.91–26.72]). Both early and late dementia incidence increased with age and was higher in women.
Infections and Early Post-Stroke Dementia
Early dementia was more common among those with any GP-recorded infection compared to those without (HR 1.44, 95% CI 1.21–1.71). Restricting to those with linked data increased the strength of association (HR 1.53, 95% CI 1.28–1.84). Effect estimates were higher again when hospitalised infections were included either as a primary diagnosis (HR 1.79, 95% CI 1.52–2.11), or as any diagnosis (HR 1.84, 95% CI 1.58–2.14): Table 2, appendix 3. There was no evidence of effect modification with recurrent stroke (p=0.493). Excluding infections in the first 3 months did not affect results (appendix 4)
Table 2 Rates of Early and Late Post-Stroke Dementia by Infection Status, and Results from Cox Regression Models
Infections and Late Post-Stroke Dementia
For late dementia, while the crude incidence was raised among those who had experienced a GP-recorded infection, adjustment for confounders removed any association (HR 1.05, 95% CI 0.96–1.16). In the sensitivity analyses restricted to those with linked data, there was some evidence that infections were associated with late dementia, with stronger effects seen for exposure definitions that include hospitalised infections (HR 1.36, 95% CI 1.23–1.50 for infection as primary diagnosis) than for GP-recorded infections (HR 1.10, 95% CI 0.99–1.22) (Table 2, appendix 3). Again, there was no evidence of effect modification with recurrent stroke. Excluding infections in the first 3 months did not change results.
Number and Type of Infections and Post-Stroke Dementia
Increasing number of GP-recorded infections were associated with early dementia (LRT for trend: 0.0002), although only small numbers had ≥2 infections (Table 3). When exposure was expanded to include hospitalised infections, there was an upward trend with increasing number of infections, although confidence intervals overlapped. We saw a strong association between LRTI or UTI as first infection and early dementia (HR 1.46, 95% CI 1.16–1.83, HR 1.61, 95% CI 1.26–2.04 respectively), which was not seen for SSTI, though numbers with dementia were small (n=22). There was an association between an increasing number of GP-recorded infections and late dementia (LRT for trend: 0.023), which was stronger when hospital infections were included (LRT for trend: <0.001). Infection type was not associated with late dementia (p=0.272, appendix 5).
Table 3 Rates of Dementia by Number of Infections, and Results from Cox Regression Models
We showed a 44% increase in early dementia among stroke survivors with common infections recorded by the GP after adjusting for other factors, in a UK population cohort of >60,000 individuals. The association was robust to a range of sensitivity analyses and became stronger when hospitalisations with infection were included. While there was little evidence that GP-recorded infection was associated with late dementia, an association was seen when infection hospitalisations were included. These findings suggest that better prevention or management of common infections following stroke may help to improve outcomes including preserving cognitive function, although further work is needed to disentangle the effect of stroke severity on this relationship.
In our study, 7.5% of patients developed dementia from 3 months to five years after stroke, which is at the lower end of the reported range for post-stroke dementia incidence.2,4 This may be due to its population-based nature. We also identified dementia diagnoses from routine EHRs, in contrast to some other cohort studies which conducted universal cognitive testing. While the positive predictive value of a dementia diagnosis in EHR data is generally high (>75%), sensitivity is lower.17 In addition, our study excluded dementia diagnoses in the first 3 months after stroke as acute brain injury post-stroke can temporarily affect cognition.
Estimates of the risk of post-stroke infections vary depending on study population, timing and methods used to identify infections. In a meta-analysis of 87 studies assessing infection in the acute phase after stroke, the pooled infection rate was 30% (95% CI 24% to 36%),18 in contrast to our study which found that 6% of patients experienced an infection in the first 3 months. However, the meta-analysis included patients with all premorbid conditions and those who died shortly after stroke, whereas for inclusion in our study, patients had to survive for at least 3 months post-stroke and have no history of dementia. In this population of stroke survivors, we showed that 34.7% had an infection up to 5 years after stroke. Validation studies show that 93% of infections recorded in EHRs can be confirmed by an additional information source.19
Strengths and Limitations of the Study
Using routinely collected electronic health data increases the power and generalisability of findings as well as overcoming some methodological difficulties that may hamper traditional cohort studies of post-stroke dementia, such as ascertainment bias. In addition, there is good capture of demographic and clinical covariates, while completeness and accuracy of diagnoses were enhanced through linkage to hospital data. Diagnoses of stroke, infections and dementia all demonstrate a high positive predictive value in EHRs. Although only around two thirds of dementia patients have a formal diagnosis in their primary care record,20 as our study population all had incident strokes and visited the GP regularly, any misclassification of dementia is unlikely to be differential by exposure status. While it is possible that reversible confusion, e.g., induced by infections or persisting beyond three months of stroke could be misclassified as dementia, usual clinical practice is to assess trajectories of cognitive change and functional status over time. In addition, current guidance in England and Wales recommends referral to a specialist dementia diagnostic service such as a memory clinic if dementia is suspected after reversible causes of cognitive change have been investigated,21 so this seems less likely. Nevertheless, we cannot exclude some degree of reverse causality, in which individuals with early undiagnosed dementia may develop more infections after stroke, perhaps through poorer nutritional status or self-care, especially as pre-stroke cognition is not routinely captured in EHRs.
In our analysis we were unable to assess severity and location of stroke, which may be predictors of infection and are linked to dementia risk.3 We did however limit to those who survived for at least three months which would exclude the most severe strokes. Other studies have shown that both immediate and later infections after stroke are associated with poorer long-term functional outcomes and mortality, independent of any effect of stroke severity.22–24 In addition, our findings remained similar when excluding infections occurring in the first 3 months, which are likely to be associated with more severe strokes. Only 65% of participants had linked data so contributed to the analyses of hospital infections, but these additional sensitivity analyses confirmed findings for the whole cohort. Therefore, while over diagnosis of infections in primary care due to lack of diagnostic tests could lead to misclassification of exposure, this is unlikely to have significantly affected findings. Some potential confounders such as education are not recorded in routine health data, although we used IMD level as a proxy. Nevertheless, there may be other relevant unmeasured factors such as dysphagia after stroke or urinary catheterization, which could be linked to stroke severity and also to likelihood of infections. We used data from after the introduction of the Quality and Outcomes Framework in 2004, which markedly improved the completeness of primary care recording.8
Impaired immunity is common after stroke and increases susceptibility to infections.25 Systemic inflammation, which impacts the progression of cardiovascular disease, could partly explain the association between infections and post-stroke dementia.26,27 Major infection can also result in inflammatory brain changes, for example, in multiple sclerosis about one third of all relapses are associated with a systemic infection, with increased immune activation seen on brain imaging.28 Infections are also well-recognised to contribute to delirium, which is present in about 20% of all general hospital inpatients, increasing to over 30% in those >80 years old and 27% in stroke patients,29,30 and is an independent risk factor for dementia.31
Our study found evidence of an association between common infections and post-stroke dementia in a large cohort of UK stroke survivors using linked routine health data. Future research to investigate this relationship would benefit from including markers of stroke severity and repeated standardised measures of cognition to investigate trajectories of a broader range of cognitive outcomes over time. Better understanding of this relationship will help to inform the development and targeting of interventions such as vaccines or early antibiotic use to prevent and treat infections after stroke and perhaps thereby preserve cognitive function.
The abstract of this article was presented at the Society for Academic Primary Care Annual Scientific Meeting 2018 as a conference talk with interim findings. The abstract was published on the conference website: https://sapc.ac.uk/conference/2018/abstract/effect-of-major-common-infections-incidence-of-post-stroke-dementia-cohort. In addition, a summary of each study using CPRD data is available on the CPRD website: https://cprd.com/protocol/effect-major-common-infections-incidence-post-stroke-dementia-cohort-study-using-uk We thank Krishnan Bhaskaran for providing advice on statistical analysis and Sara Thomas for providing some codelists.
Charlotte Warren-Gash reports grants from Wellcome during the conduct of the study. This work was supported by a Wellcome Intermediate Clinical Fellowship to CWG (201440_Z_16_Z). The authors report no other potential conflicts of interest for this work.
1. The Stroke Association. State of the nation stroke statistics [Internet]; 2018. Available from: https://www.stroke.org.uk/sites/default/files/state_of_the_nation_2018.pdf.
2. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009;8(11):1006–1018. doi:10.1016/S1474-4422(09)70236-4
3. Mijajlović MD, Pavlović A, Brainin M, et al. Post-stroke dementia – a comprehensive review. BMC Med. 2017;15(1):11. doi:10.1186/s12916-017-0779-7
4. Leys D, Hénon H, Mackowiak-Cordoliani M-A, Pasquier F. Poststroke dementia. Lancet Neurol. 2005;4(11):752–759. doi:10.1016/S1474-4422(05)70221-0
5. Cordonnier C, Hénon H, Derambure P, Pasquier F, Leys D. Early epileptic seizures after stroke are associated with increased risk of new-onset dementia. J Neurol Neurosurg Psychiatry. 2007;78(5):514–516. doi:10.1136/jnnp.2006.105080
6. Ojagbemi A, Ffytche DH. Are stroke survivors with delirium at higher risk of post-stroke dementia? Current evidence and future directions. Int J Geriatr Psychiatry. 2016;31(12):1289–1294. doi:10.1002/gps.4506
7. Hickman S, Izzy S, Sen P, Morsett L, El Khoury J. Microglia in neurodegeneration. Nat Neurosci. 2018;21(10):1359–1369. doi:10.1038/s41593-018-0242-x
8. Herrett E, Gallagher AM, Bhaskaran K, et al. Data resource profile: clinical practice research datalink (CPRD). Int J Epidemiol. 2015;44(3):827–836. doi:10.1093/ije/dyv098
9. Herbert A, Wijlaars L, Zylbersztejn A, Cromwell D, Hardelid P. Data resource profile: hospital episode statistics admitted patient care (HES APC). Int J Epidemiol. 2017;46(4):1093–1093i. doi:10.1093/ije/dyx015
10. Woodfield R, Grant I, Sudlow CLM; UK Biobank Stroke Outcomes Group, UK Biobank Follow-Up and Outcomes Working Group, Sudlow CLM. Accuracy of electronic health record data for identifying stroke cases in large-scale epidemiological studies: a systematic review from the UK biobank stroke outcomes group. PLoS One. 2015;10(10):e0140533. doi:10.1371/journal.pone.0140533
11. Millett ERC, Quint JK, Smeeth L, Daniel RM, Thomas SL, Heimesaat M. Incidence of community-acquired lower respiratory tract infections and pneumonia among older adults in the United Kingdom: a population-based study. PLoS One. 2013;8(9):e75131. doi:10.1371/journal.pone.0075131
12. McDonald HI, Nitsch D, Millett ERC, Sinclair A, Thomas SL. New estimates of the burden of acute community-acquired infections among older people with diabetes mellitus: a retrospective cohort study using linked electronic health records. Diabet Med J Br Diabet Assoc. 2014;31(5):606–614. doi:10.1111/dme.12384
13. Francis NA, Hood K, Lyons R, Butler CC. Understanding flucloxacillin prescribing trends and treatment non-response in UK primary care: a clinical practice research datalink (CPRD) study. J Antimicrob Chemother. 2016;71(7):2037–2046. doi:10.1093/jac/dkw084
14. Mathur R, Hull SA, Badrick E, Robson J. Cardiovascular multimorbidity: the effect of ethnicity on prevalence and risk factor management. Br J Gen Pract. 2011;61(586):e262–270. doi:10.3399/bjgp11X572454
15. Mathur R, Grundy E, Smeeth L. Availability and use of UK based ethnicity data for health research. Natl Cent Res Methods Work Pap Ser. 2013;1–30.
16. Department for Communities and Local Government. English indices of deprivation 2015 [Internet]; 2016. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/579151/English_Indices_of_Deprivation_2015_-_Frequently_Asked_Questions_Dec_2016.pdf.
17. Wilkinson T, Ly A, Schnier C, et al. Identifying dementia cases with routinely collected health data: a systematic review. Alzheimers Dement. 2018;14(8):1038–1051. doi:10.1016/j.jalz.2018.02.016
18. Westendorp WF, Nederkoorn PJ, Vermeij J-D, Dijkgraaf MG, van de Beek D. Post-stroke infection: a systematic review and meta-analysis. BMC Neurol. 2011;20(11):110. doi:10.1186/1471-2377-11-110
19. Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ. Validation and validity of diagnoses in the general practice research database: a systematic review. Br J Clin Pharmacol. 2010;69(1):4–14. doi:10.1111/j.1365-2125.2009.03537.x
20. Alzheimer’s Research UK Dementia Statistics Hub. Dementia diagnosis rate [Internet]; 2018. Available from: https://www.dementiastatistics.org/statistics/diagnoses-in-the-uk/.
21. National Institute for Health and Care Excellence. Dementia: assessment, management and support for people living with dementia and their carers. NICE guideline[NG 97]; 2018. Available from https://www.nice.org.uk/guidance/ng97/chapter/Recommendations#diagnosis.
22. Suda S, Aoki J, Shimoyama T, et al. Stroke-associated infection independently predicts 3-month poor functional outcome and mortality. J Neurol. 2018;265(2):370–375. doi:10.1007/s00415-017-8714-6
23. Learoyd AE, Woodhouse L, Shaw L, et al. Infections up to 76 days after stroke increase disability and death. Transl Stroke Res. 2017;8(6):541–548. doi:10.1007/s12975-017-0553-3
24. Ulm L, Harms H, Ohlraun S, Reimnitz P, Meisel A. Impact of infections on long-term outcome after severe middle cerebral artery infarction. J Neurol Sci. 2012;319(1–2):15–17. doi:10.1016/j.jns.2012.05.042
25. Kamel H, Iadecola C. Brain-immune interactions and ischemic stroke: clinical implications. Arch Neurol. 2012;69(5):576–581. doi:10.1001/archneurol.2011.3590
26. Perry VH, Cunningham C, Holmes C. Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immunol. 2007;7(2):161–167. doi:10.1038/nri2015
27. Furman D, Campisi J, Verdin E, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25(12):1822–1832. doi:10.1038/s41591-019-0675-0
28. Steelman AJ. Infection as an environmental trigger of multiple sclerosis disease exacerbation. Front Immunol. 2015;19(6):520.
29. Ryan DJ, O’Regan NA, Caoimh RÓ, et al. Delirium in an adult acute hospital population: predictors, prevalence and detection. BMJ Open. 2013;3(1):e001772. doi:10.1136/bmjopen-2012-001772
30. Miu DKY, Yeung JCY. Incidence of post-stroke delirium and 1-year outcome. Geriatr Gerontol Int. 2013;13(1):123–129. doi:10.1111/j.1447-0594.2012.00871.x
31. Davis DHJ, Muniz-Terrera G, Keage HAD, et al. Association of delirium with cognitive decline in late life: a neuropathologic study of 3 population-based cohort studies. JAMA Psychiatry. 2017;75(3):244–251. doi:10.1001/jamapsychiatry.2016.3423
This work is published by Dove Medical Press Limited, and licensed under a Creative Commons Attribution License. The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/. The license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.